BridgeMD
Prevention study for Middle School and High School Students
Official title Impact of an HPV Primary Prevention Intervention on HPV Vaccination Rates Among Adolescents in the AuRA Region.
ClinicalTrials.gov ID: NCT07414719
What this study is testing
- What it's testing
- Human papillomaviruses (HPV) are very common contagious viruses: approximately 70% of men and women will be infected during their lifetime. Vaccination, recommended since 2007 for girls and since 2021 for all young people aged 11 to 14 (with catch-up vaccination possible up to age 26), remains insufficiently followed.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 11 to 17. Healthy volunteers may be eligible.
You may be able to join if
- for children :
- Girl or boy, student at a public school participating in the study
- Aged 11 to 17
- Having received an information sheet about the study and having signed a declaration of non-objection
- Whose parents have also received an information sheet and have not expressed their non-objection
You likely can't join if
- for children:
- children protected by the law Inclusion Criteria for teachers :
- Male or female, teacher at a public school participating in the study and supervising a participating class
- Aged 18 or over
- Having received an information sheet about the study and not having expressed their opposition
- Able to read, write, and understand French
See the full eligibility criteria
- for children :
- Girl or boy, student at a public school participating in the study
- Aged 11 to 17
- Having received an information sheet about the study and having signed a declaration of non-objection
- Whose parents have also received an information sheet and have not expressed their non-objection
- Able to read, write, and understand French
- Affiliated with the SS or equivalent
- for children:
- children protected by the law Inclusion Criteria for teachers :
- Male or female, teacher at a public school participating in the study and supervising a participating class
- Aged 18 or over
- Having received an information sheet about the study and not having expressed their opposition
- Able to read, write, and understand French
- Affiliated with the SS or equivalent Exclusion Criteria for teachers : \- Person specially protected by law
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Priest, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 11 years to 17 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Priest, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.